PMC:7373848 / 25962-26118 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T458","span":{"begin":37,"end":59},"obj":"Body_part"},{"id":"T459","span":{"begin":89,"end":104},"obj":"Body_part"},{"id":"T460","span":{"begin":105,"end":117},"obj":"Body_part"}],"attributes":[{"id":"A458","pred":"fma_id","subj":"T458","obj":"http://purl.org/sig/ont/fma/fma55675"},{"id":"A459","pred":"fma_id","subj":"T459","obj":"http://purl.org/sig/ont/fma/fma54540"},{"id":"A460","pred":"fma_id","subj":"T460","obj":"http://purl.org/sig/ont/fma/fma62925"}],"text":"Pinot et al. [71] reported a case of central nervous system vasculopathy with antimyelin oligodendrocyte glycoprotein antibodies in a patient with COVID-19."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T122","span":{"begin":37,"end":59},"obj":"Body_part"},{"id":"T123","span":{"begin":45,"end":59},"obj":"Body_part"}],"attributes":[{"id":"A122","pred":"uberon_id","subj":"T122","obj":"http://purl.obolibrary.org/obo/UBERON_0001017"},{"id":"A123","pred":"uberon_id","subj":"T123","obj":"http://purl.obolibrary.org/obo/UBERON_0001016"}],"text":"Pinot et al. [71] reported a case of central nervous system vasculopathy with antimyelin oligodendrocyte glycoprotein antibodies in a patient with COVID-19."}

{"project":"LitCovid-PubTator","denotations":[{"id":"465","span":{"begin":6,"end":8},"obj":"Gene"},{"id":"466","span":{"begin":134,"end":141},"obj":"Species"},{"id":"467","span":{"begin":37,"end":72},"obj":"Disease"},{"id":"468","span":{"begin":147,"end":155},"obj":"Disease"}],"attributes":[{"id":"A465","pred":"tao:has_database_id","subj":"465","obj":"Gene:79157"},{"id":"A466","pred":"tao:has_database_id","subj":"466","obj":"Tax:9606"},{"id":"A467","pred":"tao:has_database_id","subj":"467","obj":"MESH:D002493"},{"id":"A468","pred":"tao:has_database_id","subj":"468","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Pinot et al. [71] reported a case of central nervous system vasculopathy with antimyelin oligodendrocyte glycoprotein antibodies in a patient with COVID-19."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T118","span":{"begin":147,"end":155},"obj":"Disease"}],"attributes":[{"id":"A118","pred":"mondo_id","subj":"T118","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Pinot et al. [71] reported a case of central nervous system vasculopathy with antimyelin oligodendrocyte glycoprotein antibodies in a patient with COVID-19."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T449","span":{"begin":14,"end":16},"obj":"http://purl.obolibrary.org/obo/CLO_0054055"},{"id":"T450","span":{"begin":27,"end":28},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T451","span":{"begin":37,"end":59},"obj":"http://purl.obolibrary.org/obo/UBERON_0001017"},{"id":"T452","span":{"begin":37,"end":59},"obj":"http://www.ebi.ac.uk/efo/EFO_0000302"},{"id":"T453","span":{"begin":37,"end":59},"obj":"http://www.ebi.ac.uk/efo/EFO_0000908"},{"id":"T454","span":{"begin":132,"end":133},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Pinot et al. [71] reported a case of central nervous system vasculopathy with antimyelin oligodendrocyte glycoprotein antibodies in a patient with COVID-19."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T183","span":{"begin":105,"end":117},"obj":"Chemical"}],"attributes":[{"id":"A183","pred":"chebi_id","subj":"T183","obj":"http://purl.obolibrary.org/obo/CHEBI_17089"}],"text":"Pinot et al. [71] reported a case of central nervous system vasculopathy with antimyelin oligodendrocyte glycoprotein antibodies in a patient with COVID-19."}

{"project":"LitCovid-sentences","denotations":[{"id":"T228","span":{"begin":0,"end":156},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Pinot et al. [71] reported a case of central nervous system vasculopathy with antimyelin oligodendrocyte glycoprotein antibodies in a patient with COVID-19."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T838","span":{"begin":37,"end":59},"obj":"UBERON:0001017"},{"id":"T839","span":{"begin":89,"end":104},"obj":"CL:0000128"},{"id":"T840","span":{"begin":105,"end":117},"obj":"CHEBI:17089;BV_11;CHEBI:17089"},{"id":"T841","span":{"begin":118,"end":128},"obj":"GO:0042571"},{"id":"T842","span":{"begin":147,"end":155},"obj":"SP_7"}],"text":"Pinot et al. [71] reported a case of central nervous system vasculopathy with antimyelin oligodendrocyte glycoprotein antibodies in a patient with COVID-19."}

{"project":"2_test","denotations":[{"id":"32700024-32522768-64991492","span":{"begin":14,"end":16},"obj":"32522768"}],"text":"Pinot et al. [71] reported a case of central nervous system vasculopathy with antimyelin oligodendrocyte glycoprotein antibodies in a patient with COVID-19."}